Long-term PPI review
Proton Pump Inhibitors and Nutrient Deficiency Risk
Long-term PPI use can be associated with vitamin B12 deficiency and low magnesium in some people. The answer is targeted review, not a universal supplement or testing package.
PPIs can be appropriate long-term medicines, but they still deserve periodic review.
Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole and esomeprazole reduce stomach acid and are used for reflux, ulcers and other gastrointestinal conditions. Some people need them long term. Others may be taking them after the original indication has changed.
NICE lists proton pump inhibitors as a risk factor for vitamin B12 deficiency. NHS medicine information also notes that long-term omeprazole use can be associated with very low B12, while the MHRA has issued safety advice on hypomagnesaemia during prolonged PPI treatment. [1] [2] [3]
The right response is not to assume PPIs are harmful or that everyone needs a broad nutrient panel. It is to review whether the medicine is still indicated, recognise the people at higher risk and investigate symptoms or laboratory abnormalities when they arise.
Which nutrient problems are most relevant?
Vitamin B12 and magnesium are the clearest practical concerns in current UK guidance. NICE includes PPIs among medicines that increase B12-deficiency risk. [1]
The MHRA advises considering magnesium measurement before starting prolonged PPI treatment and periodically during prolonged use, particularly when a person also takes digoxin or medicines such as diuretics that can lower magnesium. [2]
This is risk-based monitoring, not a recommendation for every person to have every vitamin and mineral tested.
Do you need vitamin tests if you take omeprazole?
Not automatically. Testing is more useful when symptoms or other risk factors make deficiency plausible. Tiredness, neurological symptoms, muscle twitches, dizziness or weakness can have many causes and need clinical interpretation.
NHS information on omeprazole notes that serious side effects can include very low B12, and NHS information on esomeprazole describes low magnesium after prolonged use and B12 deficiency with longer treatment. [3] [4]
Ask what the test is meant to answer. A B12 test, magnesium level or another investigation should lead to a decision, not simply add another number to a wellness panel.
Should you stop a PPI because of nutrient concerns?
Do not stop a prescribed PPI on your own. Some conditions require ongoing acid suppression or gastroprotection. Stopping suddenly can also lead to a rebound increase in acid symptoms in some people.
A medication review should first clarify why the PPI was started, whether that indication remains, what dose is being used, whether symptoms are controlled and whether another treatment or step-down plan is appropriate.
If a nutrient problem is confirmed, the clinician may treat the deficiency while continuing the PPI, adjust the medicine, reduce the dose or review alternatives depending on the underlying condition and risk.
Symptoms can overlap with the condition the PPI is treating.
Reflux, dyspepsia, abdominal discomfort and altered bowel symptoms may continue even when acid is suppressed, and new symptoms should not be assumed to be “nutrient depletion”. Weight loss, difficulty swallowing, persistent vomiting, gastrointestinal bleeding or a clear change in symptom pattern need medical assessment.
For broader digestive assessment, the gut health and persistent digestive symptoms guide explains how previous investigations and symptom patterns are reviewed. If laboratory testing is being considered, the functional medicine testing page explains the question-led approach.
What should a good long-term PPI review cover?
- The reason the PPI was started and whether the indication remains.
- Current dose, duration and whether symptoms return when the dose changes.
- Other medicines that affect magnesium, B12 or gastrointestinal risk.
- Symptoms that could suggest deficiency or another gastrointestinal problem.
- Whether targeted laboratory testing would change management.
- Whether a step-down plan is appropriate or whether ongoing treatment remains necessary.
This keeps the review proportionate. It also avoids the two common mistakes: assuming every long-term PPI is harmful, or assuming a long-standing prescription never needs review.
A simple long-term PPI review has four parts
First, check the reason for the PPI. Reflux, ulcer disease, protection from anti-inflammatory medicines and other conditions do not all have the same treatment plan. The reason for the prescription helps decide whether it should continue.
Second, check how long the medicine has been used and at what dose. Long treatment does not prove harm, but it can change which risks deserve attention. A higher-risk person may need more review than someone using a short course.
Third, review symptoms and other medicines. Diuretics, digoxin and other treatments can matter when magnesium is a concern. A vegan diet, bowel disease or previous surgery can matter when vitamin B12 is a concern. One risk can add to another.
Fourth, decide what action follows. The answer may be to continue the PPI, reduce it, change it, test a specific nutrient or investigate a new symptom. A review is useful when it leads to a clear plan.
What does “monitoring” mean in practice?
Monitoring does not mean testing every nutrient every year. It means checking the problems that matter for the person in front of you. The MHRA advice on magnesium, for example, focuses on prolonged treatment and people with added risk from medicines such as digoxin or diuretics. [2]
Vitamin B12 is similar. NICE lists PPIs as a risk factor, but the test is most useful when the person also has symptoms or other reasons to suspect deficiency. [1]
If a result is abnormal, the next step may be repeat testing, treatment or review of the medicine. If it is normal, the clinician may look for another cause of the symptoms. The result should move the plan forward.
Bring the full report to review. Do not rely only on a portal flag. The exact value, units and lab range are needed for proper interpretation.
How can you prepare for a PPI review?
Write down the name of the PPI, the dose and how often you take it. Add the reason it was started if you know it. Note how long you have used it.
List any symptoms that are new. Keep this simple. Tiredness, weakness, muscle twitching, tingling, weight loss, trouble swallowing or bleeding should all be mentioned if present.
Bring a full medicine list. Diuretics, digoxin and other drugs can matter when low magnesium is a concern. Other medicines and diet can also affect B12 risk.
Ask one clear question at the end: do I still need this PPI at this dose? If the answer is yes, ask what should be monitored. If the answer is no, ask how the medicine should be reduced safely.
Why is a broad nutrient panel often a poor first step?
A large panel can find small changes that do not explain your symptoms. This can lead to more tests, more cost and more worry.
A targeted test is easier to use. If B12 is the concern, check B12. If low magnesium is plausible, check magnesium. Add other tests only when the history gives a reason.
The aim is not to prove that the PPI has caused harm. The aim is to keep the treatment useful and safe.
What patients say about the consultation experience.
Reviews can describe communication and consultation experience. They do not prove that a test, supplement or treatment is effective.
Read patient reviews on Google
Individual reviews do not predict diagnosis, treatment response or outcome.
“patient, understanding and kind”
Google reviewer
“warm and compassionate bedside manner”
Google reviewer
“takes incredible care to get to know her patients”
Google reviewer
Common questions
Can long-term PPIs affect vitamin B12?
Yes. NICE lists proton pump inhibitors as a risk factor for vitamin B12 deficiency, and NHS omeprazole information includes very low B12 among possible serious long-term effects. The risk is not the same for everyone, so symptoms and other risk factors should guide testing.
Can PPIs lower magnesium?
Yes, hypomagnesaemia has been reported with prolonged PPI treatment. The MHRA advises considering magnesium measurement before prolonged treatment and periodically during long-term use, particularly when a person also takes digoxin or medicines such as diuretics that can lower magnesium.
Do I need a nutrient panel if I take omeprazole?
Not automatically. A broad panel can create incidental findings without improving care. Testing is more useful when symptoms, treatment duration, other medicines or medical history create a specific concern that the result can help resolve.
Should I stop my PPI because of B12 or magnesium concerns?
Do not stop a prescribed PPI without medical advice. Some people have a continuing indication, and abrupt withdrawal can worsen acid symptoms. A medication review should balance the reason for treatment, symptom control, deficiency risk and whether step-down or alternative treatment is appropriate.
What symptoms should I mention during a PPI review?
Mention persistent tiredness, neurological symptoms, muscle twitches, dizziness or weakness, but also gastrointestinal warning symptoms such as difficulty swallowing, bleeding, persistent vomiting or unexplained weight loss. The same symptom can have several possible causes, so context matters.
How often should long-term PPI treatment be reviewed?
The interval depends on why the PPI is used and the person’s risk. The important point is that long-term treatment should remain clinically justified and that monitoring should be targeted to the risks that matter rather than following one generic vitamin-testing schedule.
Medical sources and further reading
- NICE NG239: Vitamin B12 deficiency. Lists proton pump inhibitors among common B12-deficiency risk factors.
- MHRA: PPIs and hypomagnesaemia. UK medicines-safety advice on magnesium monitoring during prolonged PPI treatment.
- NHS: Omeprazole. Current NHS information on omeprazole, including long-term side effects and medicine review.
- NHS: Esomeprazole side effects. NHS information on low magnesium and vitamin B12 deficiency during longer-term use.
Review the medicine and the nutrient risk together.
Keep the reason for acid suppression visible, test only when the result can change care, and do not stop prescribed treatment without a plan.